![Twitter 上的 ACS Division of Medicinal Chemistry:"Don't let the flu get you down, the @US_FDA has just approved #xofluza as an #antiviral to treat an influenza infection! Congrats to Shionogi and @genentech Twitter 上的 ACS Division of Medicinal Chemistry:"Don't let the flu get you down, the @US_FDA has just approved #xofluza as an #antiviral to treat an influenza infection! Congrats to Shionogi and @genentech](https://pbs.twimg.com/media/DqSuFMjX0AEGvye.jpg)
Twitter 上的 ACS Division of Medicinal Chemistry:"Don't let the flu get you down, the @US_FDA has just approved #xofluza as an #antiviral to treat an influenza infection! Congrats to Shionogi and @genentech
![Baloxavir Marboxil for Uncomplicated Influenza: Mechanism of Action & Side Effects | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives Baloxavir Marboxil for Uncomplicated Influenza: Mechanism of Action & Side Effects | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives](https://en.huatengsci.com/usr/uploads/3/201912/Baloxavir-Marboxil_1.jpg)
Baloxavir Marboxil for Uncomplicated Influenza: Mechanism of Action & Side Effects | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives
![Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study. - Abstract - Europe PMC Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7909904/bin/gr6_lrg.jpg)
Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study. - Abstract - Europe PMC
![Baloxavir Marboxil for Uncomplicated Influenza Mechanism of Action & Side Effects(1) - Flipbook by sunnyfang1419 | FlipHTML5 Baloxavir Marboxil for Uncomplicated Influenza Mechanism of Action & Side Effects(1) - Flipbook by sunnyfang1419 | FlipHTML5](https://online.fliphtml5.com/lmssb/uemm/files/large/2.jpg?1575609810)
Baloxavir Marboxil for Uncomplicated Influenza Mechanism of Action & Side Effects(1) - Flipbook by sunnyfang1419 | FlipHTML5
![Frontiers | Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections | Microbiology Frontiers | Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections | Microbiology](https://www.frontiersin.org/files/Articles/458306/fmicb-10-01327-HTML/image_m/fmicb-10-01327-g001.jpg)
Frontiers | Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections | Microbiology
![Xofluza vs. Tamiflu: Differences Between The Antiviral Flu Treatments | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives Xofluza vs. Tamiflu: Differences Between The Antiviral Flu Treatments | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives](https://en.huatengsci.com/usr/uploads/3/202008/xofluza-moa-desktop.jpg)
Xofluza vs. Tamiflu: Differences Between The Antiviral Flu Treatments | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives
![The active form of the influenza cap-snatching endonuclease inhibitor baloxavir marboxil is a tight binding inhibitor - Journal of Biological Chemistry The active form of the influenza cap-snatching endonuclease inhibitor baloxavir marboxil is a tight binding inhibitor - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/eab2e91b-014f-4d5c-a900-f45b782a2dd4/gr1_lrg.jpg)
The active form of the influenza cap-snatching endonuclease inhibitor baloxavir marboxil is a tight binding inhibitor - Journal of Biological Chemistry
![A universal dual mechanism immunotherapy for the treatment of influenza virus infections | Nature Communications A universal dual mechanism immunotherapy for the treatment of influenza virus infections | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-19386-5/MediaObjects/41467_2020_19386_Fig1_HTML.png)
A universal dual mechanism immunotherapy for the treatment of influenza virus infections | Nature Communications
![Bentham Science | Publisher of excellence for all Biomedical, Medical and Pharmaceutical Decision Makers Bentham Science | Publisher of excellence for all Biomedical, Medical and Pharmaceutical Decision Makers](https://www.eurekaselect.com/images/graphical-abstract/cdt/21/2/008.jpg)
Bentham Science | Publisher of excellence for all Biomedical, Medical and Pharmaceutical Decision Makers
![Advanced researches on the inhibition of influenza virus by Favipiravir and Baloxavir - ScienceDirect Advanced researches on the inhibition of influenza virus by Favipiravir and Baloxavir - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2590053620300458-gr1.jpg)
Advanced researches on the inhibition of influenza virus by Favipiravir and Baloxavir - ScienceDirect
![Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil | Scientific Reports Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-018-27890-4/MediaObjects/41598_2018_27890_Fig6_HTML.jpg)
Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil | Scientific Reports
![Baloxavir Marboxil for Uncomplicated Influenza: Mechanism of Action & Side Effects by sunny Fang - Issuu Baloxavir Marboxil for Uncomplicated Influenza: Mechanism of Action & Side Effects by sunny Fang - Issuu](https://image.isu.pub/191206054048-cecdd834bfa455cb6b410610525a0107/jpg/page_1_thumb_large.jpg)
Baloxavir Marboxil for Uncomplicated Influenza: Mechanism of Action & Side Effects by sunny Fang - Issuu
![Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil | Scientific Reports Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-27890-4/MediaObjects/41598_2018_27890_Fig1_HTML.jpg)